Leadership
The leadership team at Sunesis combines successful track records in the pharmaceutical industry with a passion for advancing novel products with the potential to make a significant difference in the treatment of cancer. We will measure our success by the commercialization of novel therapeutics emerging from a stable pipeline of products that both create shareholder value and improve people's lives.
Sunesis is developing voreloxin in both AML and ovarian cancer.
Be a part of the team that will revolutionize the discovery and development of oncology treatment.
Copyright © Sunesis Pharmaceuticals, Inc. 2007. All Rights Reserved.